Literature DB >> 32436050

Large Multifocal Hepatocarcinoma: Technical Details of Treatment with Combined Transarterial Chemoembolization, Microwave and Radiofrequency Ablation.

Enrico Boninsegna1, Emilio Simonini2, Stefano Crosara2, Michela De Angelis3, Luigi Boccia3, Stefano Colopi2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 32436050     DOI： 10.1007/s12029-020-00416-w

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  10 in total

1.  The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  Masahiko Koda; Masaru Ueki; Yoshiko Maeda; Ken-Ichi Mimura; Kinya Okamoto; Yoshiko Matsunaga; Manri Kawakami; Keiko Hosho; Yoshikazu Murawaki
Journal:  Hepatol Res       Date:  2004-05       Impact factor: 4.288

2.  Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function.

Authors:  Sung Noh Hong; Sun-Young Lee; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Jong Chul Rhee; Dongil Choi; Hyo Keun Lim; Kwang-Woong Lee; Jae Won Joh
Journal:  J Clin Gastroenterol       Date:  2005-03       Impact factor: 3.062

3.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman; Luigi Solbiati; Thomas J Vogl; Bradford J Wood; Suresh Vedantham; David Sacks
Journal:  J Vasc Interv Radiol       Date:  2009-07       Impact factor: 3.464

4.  Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.

Authors:  Rusi Zhang; Lujun Shen; Long Zhao; Zhaoming Guan; Qifeng Chen; Wang Li
Journal:  Diagn Interv Radiol       Date:  2018-07       Impact factor: 2.630

5.  Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.

Authors:  Manabu Morimoto; Kazushi Numata; Masaaki Kondou; Akito Nozaki; Satoshi Morita; Katsuaki Tanaka
Journal:  Cancer       Date:  2010-07-29       Impact factor: 6.860

6.  Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma.

Authors:  Won Hyeok Choe; Young Jun Kim; Hee Sun Park; Sang Woo Park; Jeong Han Kim; So Young Kwon
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

7.  Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.

Authors:  Jong Woo Kim; Jin Hyoung Kim; Hyung Jin Won; Yong Moon Shin; Hyun-Ki Yoon; Kyu-Bo Sung; Pyo Nyun Kim
Journal:  Eur J Radiol       Date:  2011-02-25       Impact factor: 3.528

8.  Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Haruyuki Takaki; Hajime Yokoi; Masanobu Usui; Hiroyuki Sakurai; Shuji Isaji; Katsuya Shiraki; Hiroyuki Fuke; Shinji Uemoto; Kan Takeda
Journal:  Radiology       Date:  2008-02-27       Impact factor: 11.105

9.  A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.

Authors:  Jia-Yan Ni; Zhu-Ting Fang; Hong-Liang Sun; Chao An; Zhi-Mei Huang; Tian-Qi Zhang; Xiong-Ying Jiang; Yao-Ting Chen; Lin-Feng Xu; Jin-Hua Huang
Journal:  Eur Radiol       Date:  2020-01-03       Impact factor: 5.315

10.  Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm.

Authors:  Lei Zheng; Chi-Hao Zhang; Jia-Yun Lin; Chen-Lu Song; Xiao-Liang Qi; Meng Luo
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.